Pathology Update 2021
Jun
2
to Jun 4

Pathology Update 2021

  • International Convention Centre Sydney (map)
  • Google Calendar ICS

AGRF is proudly sponsoring Pathology Update in New South Wales from 20th-22nd March, 2020.

Our New South Wales and Australian Capital Territory Account Manager Oliver Distler will be attending the three-day event along with key clinical genomics contacts Maria Ricci, Melanie O’Keefe and Desley Pitcher. AGRF and will have an exhibition booth set up at the conference - find us at booth number 42!

Pathology Update is the annual scientific meeting for the Royal College of Pathologists of Australasia. Pathology Update covers the scientific disciplines of Anatomical, Chemical, Forensic, Genetic, General, Haematology, Immunopathology and Microbiology.

View Event →

Lorne Cancer 2021
Feb
13
to Feb 15

Lorne Cancer 2021

  • Cumberland Lorne Resort (map)
  • Google Calendar ICS

AGRF is proudly sponsoring the Lorne Cancer Conference from 13th-15th February 2021 in Victoria.

Our Account Managers Glenn D’Cunha (Victoria and New Zealand) and Anna Ikonomopoulos (Victoria and Tasmania) will be attending the conference and have an exhibition booth at the event.

Let us know if you’d like to meet with them during the event, or swing by our AGRF booth (number 23) and say hi - they’re looking forward to seeing you!

View Event →
Complex Diseases Webinar Series
Jan
28
2:00 PM14:00

Complex Diseases Webinar Series

Email Banner - Complex Diseases.png

We are delighted to invite you to our exclusive and free webinar series on Complex Diseases, to be held during December 2020 and January 2021. Please see webinar dates and speaker information below.

Michel Hildebrand-2.jpg

Assoc. Prof. Michael Hildebrand

Thursday 28th January, 2:00pm AEDT

Our fourth speaker is Associate Professor Michael Hildebrand with his talk “Somatic Mutation: The Hidden Genetics of Epilepsy

Abstract

Epilepsy is a common disorder with a ~3-4% lifetime risk. In about 20-30% of cases there is a clear acquired cause (e.g., head trauma or stroke), but in the remaining group, genetic factors often play a role. The most common group, focal epilepsies (FEs), account for ~ 60% of all epilepsies. Some FEs, such as those caused by brain malformations, are amenable to resective surgery, allowing privileged access to brain tissue. Genetic analysis of epileptogenic brain malformations has revealed both inherited and de novo variants in genes of the mTOR and other pathways in a growing number of cases. Within these brain abnormalities (lesions) the pathogenic variants are present in only a fraction of the cells (mosaicism), yet this is sufficient to disrupt neuronal development and lead to FE.

The first step towards rational precision medicine treatments for FE, targeting the underlying neurobiological basis of seizures, is precision diagnosis for individual patients. The overall contribution of mosaic variants, and their associated developmental pathways, to FE is not known, and is limited by the current need for brain tissue to identify most mosaic FE-related variants. Novel, minimally invasive approaches are required to detect mosaic variants in patients with FE using alternate sources of DNA, particularly for patients with ‘non-lesional’ FE (i.e. without neuroimaging evidence of a lesion) and no brain tissue available for analysis.

Register for this webinar here


Previous Webinars in the Series

 
Professor Stephen Harrap

Professor Stephen Harrap

Prof. Stephen Harrap

Tuesday 1 December, 11:00am AEDT

Our first speaker is Professor Stephen Harrap with his talk ‘Blink and You'll Miss It – a Common New Cardiovascular Phenotype with Genetic Credentials.’

Abstract

The normal cardiovascular (CV) responses to standing involve a transient fall in blood pressure (BP) within the first 20 seconds. In 3104 healthy young adults we examined the concomitant change in cardiac output (CO) on standing and discovered a bimodal distribution; with 34% of subjects experiencing a fall (COF) rather than the expected rise (COR) in CO. Other characteristics suggested the COF phenotype might be explained by problems with sympathetic nervous transmission. The COF phenotype was reproducible but not immutable, being mitigated by sympathetic activation and mimicked by vascular relaxation. We undertook a case-control (n=689) genome-wide association study (GWAS) that suggested association (P=2.05x10-6) with the exonic SNP that encoded a missense and functional variant in a gene involved in synaptic transmission. This common new phenotype provides potential new insights into physiological control and avenues to reduce risks of cardiovascular disease.

Biography

Stephen Harrap is Professor of Physiology at the University of Melbourne and a consultant physician at the Royal Melbourne Hospital. He has long-standing research interests in the genetics of common cardiovascular conditions with contributions in both man and experimental models. He has also played a major role in international clinical trials of stroke prevention (PROGRESS) and cardiovascular protection in diabetes (ADVANCE) respectively. He is a past President of the International Society of Hypertension and the High Blood Pressure Research Council of Australia.

Register for this webinar here.



Associate Professor Simon Laws

Associate Professor Simon Laws

Prof. Simon Laws

Thursday 3 December, 10:30am AWST

Our second speaker is Professor Simon Laws who will present a talk titled ‘Exploring the impact of gene combinations and gene-lifestyle interactions on Alzheimer’s Disease progression.’

Biography

Professor Simon Laws completed his PhD at the University of Western Australia in 2003. He spent his early postdoctoral career in Germany at the Technical University of Munich before returning to Australia in 2009. He is currently the Associate Dean of Medical and Exercise Science within Edith Cowan University’s School of Medical and Health Sciences. Prof Laws also leads the Collaborative Genomics and Translation Group, part of ECU’s forthcoming Centre for Precision Health for which he is the designated director of.

His research primarily focuses on understanding genomic (including genetic variation, epigenetic change and transcriptomic) influences on Alzheimer’s Disease risk and progression and their impact on Alzheimer’s disease related phenotypes, such as rates of change in memory performance and development of pathological features. This includes the validation of existing and development of novel polygenic risk scores, with a particular emphasis on the preclinical stages of disease.

Prof. Laws has published over 135 peer-reviewed journal articles and attracted research funding from both industry and nationally competitive funding bodies, such as the National Health and Medical Research Council (NHMRC). He recently received NHMRC funding to develop risk and resilience profiles for Alzheimer’s disease that incorporate genomic data with modifiable lifestyle factors and to explore the interaction of these and their impact on risk and progression of the disease.

Register for this webinar here.


Cristina Fortuno

Tuesday 8 December, 1:30pm AEST

Our third speaker is Cristina Fortuno who will present a talk titled ‘Genetic testing for health and wellness: a commercial experience using GSA.’

Biography

Cristina Fortuno (MSc, PhD) holds a Master of Science in Biotechnology from the Polytechnic University of Valencia, Spain.

Headshot_Cristina Fortuno.jpg

After gaining experience working in a reproductive genetics laboratory as a research assistant, she got a scholarship to pursue a PhD in Human Genetics at the University of Queensland, Australia.

Cristina co-authored 3 peer-reviewed journal articles during her undergraduate studies, and published 7 additional articles as a first author during her PhD. She is currently working as the product development lead at Fitgenes, an Australian-based genetic testing company focused on health and wellness.

Cristina is strongly motivated by the use of genomics in health care, as a tool to improve diagnosis, deliver personalised interventions, or find out more about an individual’s predisposition to certain health traits.

Register for this webinar here

View Event →
EpicSA Meeting
Nov
26
12:00 PM12:00

EpicSA Meeting

AGRF is sponsoring the People’s Choice Award at the EpiCSA Meeting, which will be held as an online meeting this year. The event will take place for two hours a day from November 24th-26th. The EpiCSA People’s Choice Award will be awarded for the best presentation from the submitted abstracts and voted by those attending the meeting.

View Event →
HGSA Virtual Meeting
Nov
24
to Nov 25

HGSA Virtual Meeting

AGRF will have a virtual exhibition booth at the first HGSA Virtual Conference, to be held on Tuesday 24 and Wednesday 25 November 2020. The meeting, which is presented by the Human Genetics Society of Australasia, is timed to be accessible to all members across Australasia and delegates will be able to watch presentations in real-time, and interact with speakers and ask questions.

View Event →
SCMB Research Students Symposium
Nov
19
9:00 AM09:00

SCMB Research Students Symposium

AGRF is sponsoring the University of Queensland’s School of Chemistry and Molecular Biosciences (SCMB) Research Students Symposium on 19th November. The SCMB Research Students Symposium is an annual event held to showcase the research achievements of postgraduate and Honours students in the School.

View Event →
ASMR Medical Research Week
Nov
11
to Nov 12

ASMR Medical Research Week

AGRF is sponsoring the virtual ASMR Medical Research Week® Symposium on the 11th-12th November, showcasing exciting medical research from Western Australian researchers and emerging students. The event is part of the Australian Society of Medical Research (ASMR) Medical Research Week® which will be held from Monday the 9th to Sunday the 15th of November.

View Event →
ICQG6 International Conference of Quantitative Genetics
Nov
3
to Nov 13

ICQG6 International Conference of Quantitative Genetics

AGRF will have a virtual exhibition booth at the ICQG6 International Conference of Quantitative Genetics which will run from 3rd November to 13th November. The program will be delivered across a two-week period, with three 1.5-hour program blocks per day. The program has been designed to maximise the live viewing and presenting opportunity for all attendees.

View Event →
Single Cell RNA Sequencing Webinar
Oct
14
11:00 AM11:00

Single Cell RNA Sequencing Webinar

We are excited to invite you to join us for an exclusive free online event, presented with the Centre for Tropical Bioinformatics and Molecular Biology, to hear about Single Cell RNA Sequencing. Dr Jafar Jabbari, our Senior Scientist - Innovation & Development, will present a talk on our 10X Chromium and Single Cell Sequencing capabilities at AGRF and you'll have the opportunity to ask him questions after his talk.

View Event →